Variables | unsuppressed viremia | suppressed viremia | p Value | ||
Frequencies (n/N) | Percentage | Frequencies (n/N) | Percentage | ||
Therapeutic regimen* |
|
|
| ||
· ABC-3TC-EFV | 46/118 | 39 | 121/211 | 57.3 | 0.018 |
· ABC-3TC-LPV/r | 30/118 | 25.4 | 36/211 | 17.1 | |
· AZT-3TC-NVP | 15/118 | 12.7 | 11/211 | 5.2 | |
· TDF-3TC-EFV | 11/118 | 9.3 | 22/211 | 10.4 | |
· AZT-3TC-EFV | 5/118 | 4.2 | 10/211 | 4.7 | |
· ABC-3TC-NVP | 4/118 | 3.4 | 5/211 | 2.3 | |
· ABC-3TC-AZT | 2/118 | 1.7 | 1/211 | 0.5 | |
· ABC-3TC-TDF |
|
| 1/211 | 0.5 | |
· AZT-3TC-LPV |
|
| 2/211 | 1 | |
· Not mentioned | 5/118 | 4.2 | 2/211 | 1 | |
Cotrimoxazole |
| ||||
· Start | 69/118 | 58.5 | 123/211 | 58.3 | 0.34 |
· Ongoing | 9/118 | 7.6 | 18/211 | 8.5 | |
· No | 22/118 | 18.6 | 26/211 | 12.3 | |
· Not mentioned | 18/118 | 15.3 | 44/211 | 20.9 | |
Compliance to ART** |
| ||||
· Yes | 64/118 | 43 | 185/211 | 87.7 | <0.0001 |
· No | 51/118 | 54 | 16/211 | 7.6 | |
· Not mentioned | 3/118 | 3 | 10/211 | 4.7 | |
Reason for non-compliance |
|
|
| ||
· Oversight | 6/118 | 5.1 | - | - | |
· Non-compliance with prescriptions | 5/118 | 4.2 | - | - |